VANCOUVER – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6), (the ‘Company’ or ‘MindBio’), a clinical stage biopharma company pioneering...
“We live in a “fix-it” culture with an expectation there’s a solution to every problem. But death is not a problem to solve. As has been...
Psilocybe fungi, known colloquially as “magic mushrooms,” have held deep significance in Indigenous cultures of Mesoamerica for centuries. They captured...
The Nasdaq index was smashed last week, giving up 3.8% after Apple's untimely demise at the hands of downgrading analysts. ... Read More The post Tech...
Concerns have been mounting among executives and board members about the behavior of Tesla (NASDAQ: TSLA) and SpaceX CEO Elon The post Elon Musk Faces...
Psychedelics firms are staking their claim in the biotech industry. The post Psychedelic Firms to Present at JP Morgan Healthcare Conference This Week...
If you’re interested in becoming a psychedelic therapist, deciding on how to train as one can be a bit of a minefield. There are now many...
MAPS Public Benefit Corporation (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing....
Sexual abuse during psychedelic treatments continues to be a major issue within the industry. Sexual misconduct does happen during psychedelic treatments,...
–Recently announced positive Phase 2 topline data in Major Depressive Disorder (“MDD”) with 79% of patients in remission from depression after two...
Substances being produced at a more rapid rate this year will include psilocybin, DMT and delta-9 THC The post DEA sharply increases quantities of psychedelics,...
Beckley Psytech focuses on short duration psychedelic drug treatments. The post Atai Makes $50 Million Investment Into Beckley Psytech appeared first on...
The study also found a "statistically significant reduction" in suicidal ideation from participants. The post New Ibogaine Study for Vets Finds Positive...
The move marks a departure from the firm's previous reliance on philanthropic funding. The post Lykos Therapeutics Secures $100M in Series A Funding,...
“Neuroplasticity and Psychedelics” is a live webinar event brought to you by Wondermed and Neuly. It will be held on Monday, January 15th at 3pm ET....
The firm is targeting the FDA’s 505(b)(2) pathway for a potentially expedited approval process. The post Silo Pharma Proceeds with Ketamine Implant for...